-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

614. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Minimal Residual Disease in Diagnosis and Prognosis: Poster II

Symposia: Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Minimal Residual Disease in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Chantal Lucini, PhD*, Isabella Sponseiler, MSc*, Julia Senkiv, PhD*, Anna-Maria Bandian, MSc* and Thomas Lion, MD, PhD, MSc*

St.Anna Children´s Cancer Research Institute (CCRI), Vienna, Austria

Bram S.J. Lim1*, Holly J. Whitfield1*, Mi K. Trinh1*, Gianna Bloye2*, Rebecca Thomas3*, Nathaniel D. Anderson1*, Anna Wenger1*, Angus Hodder, MBBS3,4*, Taryn D. Treger1,5,6*, Henry Lee-Six1,5*, Tim H.H. Coorens, PhD7*, Conor Parks1*, Toochi Ogbonnah1*, Petri Pölönen, PhD8, Charles G. Mullighan, MBBS, MSc, MD8, David T. Teachey, MD9, Melanie M Hagleitner, MD10*, Lennart A. Kester, PhD10*, Frank N. van Leeuwen, PhD11, Gordon Beattie2*, Marc R. Mansour, MD, PhD, FRCPath2,12*, Owen Williams12*, Jack Bartram3*, Stuart Adams3*, Laura Jardine13*, Sam Behjati, BMBCh, PhD1,5,6* and David O'Connor, MD2,3,12*

1Wellcome Sanger Institute, Hinxton, United Kingdom
2UCL Cancer Institute, London, United Kingdom
3Great Ormond Street Hospital for Children, London, United Kingdom
4Wellcome Sanger Institute, London, United Kingdom
5Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
6Department of Paediatrics, University of Cambridge, Cambridge, United Kingdom
7Broad Institute of MIT and Harvard, Cambridge, MA
8Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
9Children's Hospital of Philadelphia, Philadelphia, PA
10Princess Maxima Center for pediatric oncology, Utrecht, Netherlands
11Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands
12UCL Great Ormond Street Institute of Child Health, London, United Kingdom
13Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom

Ilaria Di Fazio1*, Lena Behrmann, PhD2*, Valerie de Haas, MD, PhD3*, Victoria Dimitrova1*, Joaquin Duarte, MD4*, Gabriele Escherich, MD5*, Arja Harila, MD, PhD6*, Mats Heyman, MD, PhD7,8, Mattias Hofmans, MD, PhD9*, Magnus Hultdin, MD, PhD10*, Inga Johannsdottir, MD11*, Andrea Malone, MD12*, Hanne Vibeke Marquart, MD, PhD13*, Reda Matuzeviciene14*, Veerle Mondelaers, MD15*, John Moppett, MD, PhD16*, Liv T. N. Osnes, MD, PhD17*, Samuli Rounioja, MD, PhD18*, Kjeld Schmiegelow, MD, DMsc19, Mervi Taskinen, MD20*, Goda Vaitkeviciene, MD, PhD21*, Inge M. van der Sluis, MD, PhD3, Lucy Wheeler22* and Christina Halsey, MD, PhD23

1School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom
2University Medical Center Hamburg-Eppendorf, Hamburg, Sweden
3Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
4Portuguese Institute of Oncology of Lisbon, Lisbon, Portugal
5University Medical Center Hamburg-Eppendorf, Hamburg, Germany
6Women's and Children's Health, Uppsala University, Uppsala, Sweden
7Childhood Cancer Research Unit, Karolinska Institute, Stockholm, Sweden
8Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden
9Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium
10Umeå University, Umeå, Sweden
11Department of Pediatric Hematology and Oncology, Oslo University Hospital Rikshospitalet, Oslo, Norway
12Children’s Health Ireland, Dublin, IRL
13Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark
14Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
15Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium
16Department of Paediatric Haematology, Bristol Royal Hospital for Children, Bristol, United Kingdom
17Oslo University Hospital, Department of Immunology, Oslo, Norway, NOR
18Fimlab Laboratories, Department of Haematology, Tampere University Hospital, Tampere, Finland
19Department of Pediatrics and Adolescent Medicine, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark
20Children and Adolescents, Helsinki University Hospital, Helsinki, Finland
21Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
22Southmead Hospital, North Bristol NHS Trust, Bristol, United Kingdom
23Wolfson Wohl Cancer Research Centre, School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom

Sarah Sandmann1*, Marcel Te Vrugt2*, Gerrit Randau2*, Thomas Beder3,4,5*, Martin Neumann, MD3*, Amelie Alfert2*, Cornelia Eckert, MD, PhD6*, Anja Moericke7*, Johanna Horns8*, Monika Brüggemann8* and Birgit Burkhardt, MD, PhD9

1Institute of Medical Informatics, University of Muenster, Muenster, DEU
2University Hospital Muenster, Department of Paediatric Hematology, Oncology and BMT and NHL-BFM study center, Muenster, Germany
3Medical Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany
4Clinical Research Unit CATCH ALL (KFO 5010/1) funded by the Deutsche Forschungsgemeinschaft, Kiel, Germany
5University Medical Center Schleswig-Holstein, University Cancer Center Schleswig-Holstein, Kiel, Germany
6Department of Pediatric Oncology and Hematology, Charité University Medical Center, Berlin, Germany
7Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Department of Pediatrics I, Pediatric Hematology/Oncology, ALL-BFM Study Group, Kiel, Germany
8Medical Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany
9University Hospital Muenster, Department of Paediatric Hematology, Oncology and BMT and NHL-BFM study center, Münster, Germany

Jingliao Zhang1, Suyu Zong2*, Yongjuan Duan3*, Bei-bei Zhao4*, Jun Li5*, Xiaoli Chen6*, Wenyu Yang, MD7*, Peng Wu8*, Xiaofan Zhu, MD7 and Yingchi Zhang1*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Co, Tianjin, CHN
4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
5State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
6State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin, CHN
7Department of Pediatric Hematology and Oncology, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences& Peking Union Medical College, Tianjin, China
8State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Tianjin, China

Marianna Ponzo, PhD1,2*, Lorenzo Drufuca, PhD3*, Chiara Buracchi, PhD1,4*, Marco M Sindoni1,4*, Silvia Nucera, MD1,4*, Cristina Bugarin, MSc1*, Ramona Bason, PhD3*, Grazisa Rossetti, PhD3*, Raul Bonnal3*, Cristian Meli5*, Benedetta Rambaldi5*, Federico Lussana6*, Silvia Ferrari, MD5*, Alex Moretti, MD1*, Giulia Risca7*, Christian Pellegrino, PhD2*, Markus G. Manz, MD2, Stefania Galimberti7*, Alessandro Rambaldi5, Andrea Biondi1,4,8, Giuseppe Gaipa1, Massimiliano Pagani, PhD3,9* and Chiara F. Magnani, PhD1,2

1Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
2Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
3The AIRC Institute of Molecular Oncology (IFOM), Milan, Italy
4School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
5Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
6Department of Oncology and Hematology, University of Milan and ASST Papa Giovanni XXIII, Bergamo, Italy
7Bicocca Bioinformatics, Biostatistics and Bioimaging Centre, Department of Medicine and Surgery, University of Milano - Bicocca, Milan, Italy
8Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
9Department of Medical Biotechnology and Translational Medicine, Università degli Studi, Milan, Italy

Colin Fortner, MSc1*, Alexandra Niedermayer, MSc2*, Stefanie Enzenmüller, PhD2*, Klaus-Michael Debatin, MD, Professor2, Felix Seyfried, MD2* and Lüder Hinrich Meyer, MD, Professor2*

1Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, AL, Germany
2Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany

Marco Beldinanzi1*, Vittorio Bellomarino1*, Deborah Cardinali, PhD1*, Irene Della Starza, PhD2*, Mabel Matarazzo1*, Mariangela Di Trani1*, Matteo Leoncin3*, Clara Minotti1*, Lara Pochintesta4*, Erika Borlenghi, MD5, Caterina Alati, MD6*, Simona Sica, MD, PhD7*, Valentina Mancini, MD8*, Barbara Scappini9*, Bianca Serio, MD10*, Marina Parisi11*, Lucia Ammirati, MD12*, Antonella Cucca13*, Federico Lussana14*, Ernesta Audisio, MD15*, Federico Mosna16*, Patrizia Zappasodi17*, Monica Bocchia, MD18*, Silvia Imbergamo19*, Mario Luppi, MD20*, Valeria Cardinali, MD, PhD21*, Crescenza Pasciolla22*, Claudio Romani23*, Albana Lico24*, Benedetta Cambò, MD25*, Massimiliano Bonifacio, MD26*, Monica Messina, PhD27*, Daniele G. Mattei, MD28, Sara Mastaglio, MD29*, Lara Aprile, PhD, MD30*, Monia Lunghi31*, Anna Guarini, PhD1*, Robin Foà, MD1* and Sabina Chiaretti, MD, PhD1

1Department of Translational and Precision Medicine, Division of Hematology, Sapienza University, Rome, Italy
2AIL Roma ODV, Rome, Italy
3Azienda Ulss3 Serenissima,Hematology Unit, Ospedale dell'Angelo, Venezia, Italy
4ASL DI PIACENZA, OSPEDALE "GUGLIELMO DA SALICETO", Piacenza, Italy
5Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
6U.O.C. Ematologia, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy
7UOC Ematologia e Trapianto Cellule Staminali Emopoietiche, Fondazione Policlinico Universitario A. Gemelli IRCCS Roma, Rome, Italy
8Department of Hematology and Oncology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
9Hematology Unit, Hematology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
10Hematology and Transplant Center, University Hospital “San Giovanni di Dio e Ruggi d’Aragona”, Salerno, Italy
11UO di Ematologia - Catania, Catania, Italy
12ASL Salerno - Presidio Ospedaliero Tortora Pagani, Pagani, Italy
13ASSL NUORO, PRESIDIO OSPEDALIERO SAN FRANCESCO, Nuoro, Italy
14Department of Oncology and Hematology, University of Milan and ASST Papa Giovanni XXIII, Bergamo, Italy
15Department of Oncology, Division of Hematology, AOU City of Health and Science of Turin, Turin, Turin, Italy
16Azienda Sanitaria dell'Alto Adige, Bolzano, ITA
17Hematology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
18Hematology, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy
19Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy
20Hematology Unit and Chair, Department of Medical and Surgical Sciences, Azienda Ospedaliera Universitaria di Modena, University of Modena and Reggio Emilia, Modena, Italy
21Department of Medicine and Surgery, Division of Hematology and Clinical Immunology, S. Maria della Misericordia Hospital, Perugia, Italy
22Ematologia, Istituto Tumori Giovanni Paolo II- Bari, Bari, Italy
23SC di Ematologia e CTMO, Ospedale Oncologico di Riferimento Regionale "A. Businco", ARNAS "G. Brotzu", Cagliari, CA, ITA
24Hematology Unit, Hematology Unit, San Bortolo Hospital, Vicenza, Italy, Vicenza, Italy
25University of Parma, Parma, ITA
26Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona, Verona, Italy
27GIMEMA Foundation, Rome, Italy
28ASO S. Croce e Carle, Cuneo, Italy
29Hematology and Bone Marrow Transplant, Unit San Raffaele Scientific Institute, Milano, Milano, Italy
30AZ. OSPEDALIERA SENESE, Siena, ITA
31Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy

Ntasha Roy, MBBS, MHA1*, Alexandra E. Kovach, MD2,3* and Brent L. Wood, MD, PhD1,2

1Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA
2Keck School of Medicine of University of Southern California, Los Angeles, CA
3Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA

Carol Fries Simpson, MD1, Lik Wee Lee, PhD2*, Hongyue Wang, PhD3*, Diana G. Adlowitz, PhD4*, Philip Rock5*, Brent L. Wood, MD, PhD6,7, Rachel E. Rau, MD8, Kara L. Davis, DO9*, Anne Angiolillo, MD10*, Meenakshi Devidas, PhD, MBA11, David T. Teachey, MD12, Karen R Rabin, MD, PhD13, Birte Wistinghausen, MD14, Donald Barkauskas, PhD15*, Robert J. Hayashi16*, Richard Burack, MD, PhD17, Carl E Allen, MD18,19, Michelle L. Hermiston, MD, PhD20 and Ilan R. Kirsch, MD21

1Department of Pediatrics, University of Rochester, Rochester, NY
2Adaptive Biotechnologies, Seattle, WA
3Department of Biostatistics, University of Rochester, Rochester, NY
4Department of Pediatrics; Department of Pathology & Laboratory Medicine, University of Rochester, Rochester, NY
5Departments of Pathology and Laboratory Medicine, Medicine, and Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
6Keck School of Medicine of University of Southern California, Los Angeles, CA
7Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA
8Ben Towne Center for Childhood Cancer Research, Seattle Children’s Hospital, Fred Hutch Cancer Center, University of Washington, Seattle, WA
9Stanford University, Stanford, CA
10Servier Pharmaceuticals, Boston, MA
11St Jude Children's Research Hospital, Memphis, TN
12Division of Oncology, Children's Hospital of Philadelphia, Rutledge, PA
13Department of Pediatrics, Baylor College of Medicine TX Children's Cancer Center, Houston, TX
14Children’s National Medical Center, Washington, DC
15Department of Population and Public Health Sciences, Keck School of Medicine of the University of Southern California, Los Angeles, CA
16Department of Pediatrics, Division of Hematology / Oncology, Washington University School of Medicine, Saint Louis, MO
17Pathology and Laboratory Medicine, University of Rochester, Rochester, NY
18Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, TX
19Texas Children's Hospital, Houston, TX
20Department of Pediatric, Division of Pediatric Hematology-Oncology, University of California San Francisco, Benioff Children’s Hospital, San Francisco, CA
21Medical Affairs, Adaptive Biotechnologies, Seattle, WA

Shu-Wei Chou, MD1*, Meng-Yao Lu, MD1*, Yung-Li Yang, MD, PhD1,2*, Hsiu-Hao Chang, MD, PhD1*, Xavier Cheng-Hong Tsai, MD, PhD3, Chia-Jui Du, MD1* and Shiann-Tarng Jou, MD, PhD1*

1Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan
2Department of Laboratory Medicine, National Taiwan University Cancer Center, Taipei, Taiwan
3Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

Yang Dai, MD, PhD1*, Bei Yu, BS2*, Jie Zhang, MS2*, Yu Wu, MD, PhD3*, Zhidong Yang, MS2*, Na Wang2*, Tong Chen, MS4*, Libo Hu, MS4*, Wanqiu Yang, MS4*, Shiang Huang, MD2,5, Ting Liu6 and Xiaofei Ye2,7*

1Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China
2Wuhan Kindstar Biotech Technology Co., Ltd, Wuhan, China
3Department of Hematology and Hematology Research Laboratory, West China Hospital, Sichuan University, Chengdu, China
4Sichuan Hua Xi Kindstar Medical Diagnostic Centre, Chengdu, China
5Kindstar Global Precision Medicine Institute, Wuhan, China
6Department of Hematology, West China Hospital of Sichuan University, Chengdu, China
7Kindstar Global Precision Medicine Institute, Wuhan, AL, China

Maria Sara Felice, MD, PhD1*, Patricia Laura Rubio, PhD2*, Jorge Gabriel Rossi, PhD1*, Jorge Digiorge, PhD1*, Elisa Olga Sajaroff, PhD1*, Myriam Ruth Guitter, MD1*, Carla Luciana Pennella, MD3*, Luisina Peruzzo, MD4*, Cristian German Sánchez La Rosa, MD2*, Hernan Zamaro, MD2* and Elizabeth Alfaro, MD1*

1Hospital Nacional de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina
2Hematology and Oncology Department, Hospital Nacional de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina
3Hospital De Pediatria J P Garrahan, Buenos Aires, ARG
4Hematology and Oncology Department, Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina

Bingqing Huang1,2*, Yujiao Jia, MD2,3*, Haoxu Wang1*, Huijun Wang3*, Qi Sun1*, Chengwen Li1*, Hui Wei, MD1,2*, Yingchang Mi, MD1,2, Xiaofan Zhu, MD2,3, Jianxiang Wang, MD1,2 and Zhijian Xiao, MD2,3*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
2Tianjin Institutes of Health Science, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China

Anmol Pardeshi1*, Charlie Zhong, MPH, MS, PhD2*, Shaobo Li, PhD1*, Catherine Metayer, MD, PhD3* and Joseph L. Wiemels, PhD1*

1Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA
2American Cancer Society, Atlanta, GA
3Division of Epidemiology, School of Public Health, University of California, Berkeley, Berkeley, CA

Gianfranco Lapietra1*, Jordi Ribera2*, Mireia Morgades2*, Neus Ruiz Xiville, PhD2*, Anna Torrent, MD3*, Mar Mallo4*, Jesus Maria Hernandez Rivas, MD5, Alberto Hernández Sánchez, MD6*, Alberto Orfao, MD, PhD7*, Isabel Granada, MD8*, Jose Tomas Navarro, MD, PhD9*, Ilaria Del Giudice10*, Maurizio Martelli, MD11*, Sabina Chiaretti, MD, PhD12 and Josep-Maria Ribera, MD, PhD13,14

1Josep Carreras Leukemia Research Institute, Badalona (ES)/ Hematology, Department of Translational and Precision Medicine, Sapienza, University of Rome (IT), Badalona, Spain
2ICO-Hospital Germans Trias i Pujol, Institut de Recerca contra la Leucèmia Josep Carreras (IJC), Universitat Autònoma de Barcelona, Badalona, Spain
3Hematology department, Institut Català D'oncologia-Hospital Germans Trias I Pujol. Josep Carrera, Badalona, Spain
4Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain
5University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain
6Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC – University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain. IBSAL (Salamanca, Spain), Salamanca, Spain
7Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain
8Haematology Department, Hospital Germans Trias i Pujol-Catalan Institute of Oncology., Badalona, Spain
9Hematology Department, ICO Badalona, Germans Trias i Pujol University Hospital. Universitat Autònoma de Barcelona. Josep Carreras Leukemia Research Institute, Badalona, Spain
10Hematology, Department of Translational and Precision Medicine, Sapienza University, Roma, Italy
11Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
12Department of Translational and Precision Medicine, Division of Hematology, Sapienza University, Rome, Italy
13Ico-Hospital Universitari Germans Trias Y Pujol, Badalona, Barcelona, ESP
14Josep Carreras Leukemia Research Institute, Badalona, Barcelona, Spain., Badalona, Spain

Amani Alqahatni, MD1*, Deepa Bhojwani, MD2 and Houda Alachkar, PhamD, PhD1,3*

1Department of Clinical and Experimental Therapeutics, School of Pharmacy, University of Southern California, Los Angeles, CA
2Hematology/Oncology, Children's Hospital of Los Angeles, Los Angeles, CA
3Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA

Vivek M. Shastri, PhD1, Jennifer Ahmed, PharmD2*, Eva Spin3*, Sonia Morales, MD4*, Anurag K. Agrawal, MD5*, Christine L. Phillips, MD6, Keith J August, MD, MS7, Erin M. Guest, MD7, Carol Hwang Lin, MD8, Beth Apsel Winger, MD, PhD9, Catherine Aftandilian, MD10, Van Thu Huynh11 and Jatinder K. Lamba, PhD1,12

1Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, FL
2Pediatrics and Women’s Pharmacy Services, UF Health Shands Children’s Hospital, Gainesville, FL
3Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, FL
4Pediatric Oncology, Children's Hospital of Orange County (CHOC), Orange, CA
5UCSF Benioff Children's Hospital, Oakland, CA
6Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
7Hematology/Oncology/BMT, Children's Mercy Kansas City, Kansas City, MO
8Division of Oncology, Hyundai Cancer Institute, Children's Hospital of Orange County, Orange, CA
9Division of Pediatric Hematology-Oncology, UCSF Benioff Children's Hospital, San Francisco, CA
10Department of Pediatrics, Division of Pediatric Hematology/Oncology, Stanford University, Palo Alto, CA
11Division of Oncology, Children's Hospital of Orange County, Orange, CA
12UF Health Cancer Center, University of Florida, Gainesville, FL

*signifies non-member of ASH